Jefferies Upgrades Azenta, Inc. (AZTA) to Buy

Jefferies analyst Matthew Stanton upgraded Azenta, Inc. (NASDAQ: AZTA) from Hold to Buy with a price target of $38.00 (from $30.00).

The analyst comments: "Focus remains on tricky 4Q (steep q/q ramp), but zooming out, we see attractive setup into '26 (+L/MSD core growth, +300bps adj. EBITDA expansion), healthy biopharma exposure (50%+), plenty of growth drivers (innovation, pricing, attach rates) and M&A upside ($550M+ of cash, or $12/sh). There is room for the multiple to re-rate (~11x EBITDA vs peers mid-teens) as confidence in the mid-term oppty builds (-1day on 12/10). Upgrade to Buy from Hold, $38 PT."

For an analyst ratings summary and ratings history on Azenta, Inc. click here. For more ratings news on Azenta, Inc. click here.

Shares of Azenta, Inc. closed at $29.79 yesterday.

You May Also Be Interested In

• Backblaze Inc (BLZE) PT Raised to $14 at Needham
• Rosenblatt Reiterates Buy Rating on Quantum Computing, Inc. (QUBT)
• Darden Restaurants (DRI) PT Raised to $235 at Guggenheim